Clinical Trial Update: Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and pharmacokinetics of Pegolsihematide in patients with myelodysplastic syndromes and related anemia is reported. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Myelodysplastic Syndromes

Drugs mentioned

• Pegolsihematide

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Myelodysplastic Syndromes, Anemia | Phase 1 | Status: UNKNOWN